Interaction of hepatitis B virus with cellular processes in liver carcinogenesis

Critical Reviews in Clinical Laboratory Sciences

Volumn 37, Issue 5, 2000, Pages 407-429

  Rabe, C ^a   Caselmann, W H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Animal; Carcinoma; Cells; Genes; Hepatitis B surface antigens *metabolism; Hepatitis B Virus genetics *metabolism ultrastructure; Hepatitis B Virology; Hepatocellular virology; Human; Non U.S. Gov't. trans activation (genetics); Support; Trans activators Metabolism

Indexed keywords

MEMBRANE PROTEIN; VIRUS PROTEIN;

APOPTOSIS; CANCER INHIBITION; CELL INTERACTION; DISEASE ASSOCIATION; DNA REPAIR; GENETIC TRANSCRIPTION; HEPATITIS B; HEPATITIS B VIRUS; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; MUTANT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALIA; HEPATITIS B VIRUS;

EID: 0034473069     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360091174277     Document Type: Review

References (207)

1. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association
2. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma
3. Distribution of five antigens in hepatocellular carcinoma
4. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma
5. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
6. Hepatitis B virus. The major etiology of hepatocellular carcinoma
7. A case-control study of primary hepatocellular carcinoma in Taiwan
8. Experimental WHV infection of woodchucks: An animal model of hepadnavirus-induced liver cancer
9. Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections
10. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans
11. Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses
12. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma
13. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis
14. Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan. Correlation with local host immune response
15. Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma
16. Analysis of integrated hepatitis B virus DNA and flanking cellular sequences in the hepatocellular carcinoma cell line HCC36
17. Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas
18. Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma
19. Inversely repeating integrated hepatitis B virus DNA and cellular flanking sequences in the human hepatoma-derived cell line huSP
20. Rearrangement of the surface antigen gene of hepatitis B virus integrated in the human hepatoma cell lines
21. A chromosome 17:7 translocation is associated with a hepatitis B virus DNA integration in human hepatocellular carcinoma DNA
22. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma
23. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma
24. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
25. Hepatitis B virus DNA integration and expression of an erb B-like gene in human hepatocellular carcinoma
26. Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line
27. Enzymatic properties of overexpressed HBV-mevalonate kinase fusion proteins and mevalonate kinase proteins in the human hepatoma cell line PLC/PRF/5
28. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma
29. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks
30. Structure and expression of hcr, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma
31. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours
32. Evidence for long-range oncogene activation by hepadnavirus insertion
33. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas
34. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis
35. Chromosome 17 allele loss in hepatocellular carcinoma but not in synchronous liver adenoma
36. Loss of heterozygosity in liver tumours
37. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma
38. Loss of somatic heterozygosity in hepatocellular carcinoma
39. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma
40. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer
41. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas
42. Allelotype study of primary hepatocellular carcinoma
43. Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma
44. p53 mutations cluster at codon 249 in hepatitis B viruspositive hepatocellular carcinomas from China
45. p53 Mutations in human hepatocellular carcinomas from Germany
46. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas
47. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma
48. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma
49. Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China
50. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
51. A t(3;8) chromosomal translocation associated with hepatitis B virus intergration involves the carboxypeptidase N locus
52. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma
53. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas
54. Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA
55. Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas
56. Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins
57. p53 gene in hepatocellular carcinomas from Australia
58. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator
59. Expression of antisense E1A in 293 cells results in altered cell morphologies and cessation of proliferation
60. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A
61. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
62. Association of human papillomavirus types 16 and 18 E6 proteins with p53
63. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas
64. Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas
65. Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators
66. Common evolutionary origin of hepatitis B virus and retroviruses
67. Transcriptional trans-activating function of hepatitis B virus
68. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state
69. The HBV X-ORF encodes a transactivator: A potential factor in viral hepatocarcinogenesis
70. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
71. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
72. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein
73. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice
74. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice
75. Long-term expression of the hepatitis B virus coree- and X-proteins does not cause pathologic changes in transgenic mice
76. In vivo activity of the hepatitis B virus core promoter: Tissue specificity and temporal regulation
77. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator
78. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA
79. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator
80. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
81. Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice
82. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters
83. Novel short transcripts of hepatitis B virus X gene derived from intragenic promoter
84. Identification of three essential regions of hepatitis B virus X protein for trans-activation function
85. Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function
86. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function
87. An internal domain of the hepatitis B virus X antigen is necessary for transactivating activity
88. Transactivating function and expression of the x gene of hepatitis B virus
89. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2
90. The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element
91. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level
92. Trans-activation of cellular genes by hepatitis B virus proteins: A possible mechanism of hepatocarcinogenesis
93. Transactivators of HBV, signal transduction and tumorigenesis
94. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex
95. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus
96. Antibodies to peptides detect new hepatitis B antigen: Serological correlation with hepatocellular carcinoma
97. The HBV HBX gene expressed in E. coli is recognized by sera from hepatitis patients
98. Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector
99. Synthesis of the X-protein of hepatitis B virus in vitro and detection of anti-X antibodies in human sera
100. Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues
101. The hepatitis B virus X gene product transactivates the HIV-LTR in vivo
102. Hepatitis B virus X gene product acts as a transactivator in vivo
103. Oncogenic potential of hepatitis B virus
104. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters
105. Hepatitis B virus X gene can transactivate heterologous viral sequences
106. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication
107. Trans-activation of viral enhancers by the hepatitis B virus X protein
108. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases
109. Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein
110. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1
111. Trans-activation by the hepatitis B virus X protein shows cell-type specificity
112. The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity
113. Modulation of expression of the hepatitis B virus surface antigen gene by the viral X-gene product
114. The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax
115. The hepatitis B virus X protein transactivates viral core gene expression In vivo
116. t: Activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization
117. The hepatitis B virus X protein transactivation of c-fos and c-myc protooncogenes is mediated by multiple transcription factors
118. Hepatitis B virus suppresses expression of human beta-interferon
119. Activation of class I major histocompatibility complex gene expression by hepatitis B virus
120. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells
121. Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter
122. Trans-activation of HLA-DR gene by hepatitis B virus X gene product
123. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
124. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors
125. Transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat by hepatitis B virus X-protein requires de novo protein synthesis
126. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions
127. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB
128. The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors
129. Human hepatitis B virus X protein augments the DNA binding of nuclear factor for IL-6 through its basic-leucine zipper domain
130. Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis
131. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein
132. Hepatitis B virus pX targets TFIIB in transcription coactivation
133. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation
134. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein
135. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH
136. pX, the Hbv-encoded coactivator, suppresses the phenotypes of Tbp and Tafii250 mutants
137. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5
138. The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators
139. D-alpha-tocopherol inhibits collagen alpha1(I) gene expression in cultured human fibroblasts
140. Trans-activation by hepatitis B virus X protein is mediated via a tumour promoter pathway
141. The hepatitis B virus X-associated protein, XAP3, is a protein kinase C- binding protein
142. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome
143. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit
144. Proteasome complex as a potential cellular target of hepatitis B virus X protein
145. The hepatitis B virus X protein: The quest for a role in viral replication and pathogenesis
146. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade
147. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases
148. Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX
149. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras
150. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors
151. Erk-independent partial activation of AP-1 sites by the hepatitis B virus HBx protein
152. Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway
153. Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein
154. HBx protein of hepatitis B virus activates Jak1-STAT signaling
155. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling
156. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha
157. The effect of hepatitis B virus X gene expression on response to growth inhibition by transforming growth factor-beta 1
158. Transcriptional regulation of type-I collagen genes
159. The hepatitis B virus HBx protein inhibits caspase 3 activity
160. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation
161. Pro-apoptotic effect of the hepatitis B virus X gene
162. X-gene product of hepatitis B virus induces apoptosis in liver cells
163. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha
164. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx
165. Effect of hepatitis B virus X protein on the expression of retinoblastoma gene product
166. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines
167. Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system
168. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
169. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct
170. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
171. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
172. Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells
173. The hepatitis B virus X gene induces p53-mediated programmed cell death
174. p53-independent apoptotic effects of the hepatitis B virus Hbx protein in vivo and in vitro
175. Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis
176. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system
177. Inhibition of hepatitis-B-virus core promoter by p53: Implications for carcinogenesis in hepatocytes
178. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein
179. Hepatitis B virus X-protein binds damaged DNA and sensitizes liver cells to ultraviolet irradiation
180. Hepatitis B virus X protein interferes with cellular DNA repair
181. Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants
182. Increased 8-hydroxy-2′-deoxyguanosine formation in liver tissues of hepatitis B virus x-transgenic mice
183. Hepatitis B virus X protein inhibits nucleotide excision repair
184. The hepatitis B virus transactivator protein, HBx, interacts with single-stranded DNA (ssDNA). Biochemical characterizations of the HBx- ssDNA interactions
185. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells
186. Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes
187. t activator
188. The hepatitis B virus pre-S/S(t) transactivator is generated by 3′ truncations within a defined region of the S gene
189. Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivator
190. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum
191. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein
192. A lag in intracellular degradation of mutant alpha 1antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency
193. t
194. t167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors
195. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation
196. Posttranslational alterations in transmembrane topology of the hepatitis B virus large envelope protein
197. A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis
198. Differences in the target specificity of the transactivating factors MHBs(t) and HBx of hepatitis B virus
199. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma
200. Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma
201. Inverse polymerase chain reaction for cloning cellular sequences adjacent to integrated hepatitis B virus DNA in hepatocellular carcinomas
202. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication
203. X protein of hepatitis B virus resembles a serine protease inhibitor
204. The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase
205. Functional and structural similarity between the X protein of hepatitis B virus and nucleoside diphosphate kinases
206. The X protein of hepatitis B virus has a ribo/deoxy ATPase activity
207. The hepatitis B virus X protein is a potent AMP kinase